Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in patients with KRAS G12D pancreatic ductal adenocarcinoma treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback